BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10196831)

  • 1. Proliferative activity of denture-induced fibrous inflammatory hyperplasia analyzed by proliferating cell nuclear antigen labeling index.
    Coelho CM; Zucoloto S
    Int J Prosthodont; 1999; 12(1):73-7. PubMed ID: 10196831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Denture-induced fibrous inflammatory hyperplasia: a retrospective study in a school of dentistry.
    Coelho CM; Zucoloto S; Lopes RA
    Int J Prosthodont; 2000; 13(2):148-51. PubMed ID: 11203624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunohistochemical study of p53 and PCNA in inflammatory papillary hyperplasia of the palate: a dilemma of interpretation.
    Kaplan I; Vered M; Moskona D; Buchner A; Dayan D
    Oral Dis; 1998 Sep; 4(3):194-9. PubMed ID: 9972170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic characteristics of esophageal epithelial dysplasia assessed by proliferating cell nuclear antigen.
    Koga Y; Kuwano H; Sugimachi K
    Cancer; 1996 Jan; 77(2):237-44. PubMed ID: 8625229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunohistochemical detection of involucrin in denture induced fibrous inflammatory hyperplasia of oral mucous membrane.
    Thomas GA
    Aust Prosthodont J; 1991; 5():29-34. PubMed ID: 1725957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory papillary hyperplasia: supraperiosteal excision by the blade-loop technique.
    Antonelli JR; Panno FV; Witko A
    Gen Dent; 1998; 46(4):390-7. PubMed ID: 9758987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing.
    Lee JJ; Kuo MY; Cheng SJ; Chiang CP; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Apr; 99(4):471-8. PubMed ID: 15772596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Denture induced inflammations.
    Miller EL
    J Dent Assoc S Afr; 1975 Jan; 30(1):89-93. PubMed ID: 802241
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between immunohistochemical evaluation of thymidylate synthase and proliferating cell nuclear antigen labeling index in gastrointestinal carcinoma.
    Kunimoto Y; Nakamura T; Ohno M; Kuroda Y
    Oncol Rep; 2004 Dec; 12(6):1163-7. PubMed ID: 15547732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic conditions of the oral mucosa associated with ill-fitting dentures: II: Inflammatory papillary hyperplasia of the palate.
    Buchner A; Helft M
    Refuat Hapeh Vehashinayim; 1979 Jan; 28(1):11-6, 9-13. PubMed ID: 289633
    [No Abstract]   [Full Text] [Related]  

  • 11. A new cell proliferating marker: cytosolic thymidine kinase as compared to proliferating cell nuclear antigen in patients with colorectal carcinoma.
    Wu J; Mao Y; He L; Wang N; Wu C; He Q; Skog S
    Anticancer Res; 2000; 20(6C):4815-20. PubMed ID: 11205225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Denture-induced fibrous inflammatory hyperplasia (epulis fissuratum): research aspects.
    Thomas GA
    Aust Prosthodont J; 1993; 7():49-53. PubMed ID: 8695194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometrial carcinoma.
    Hamid AA; Mandai M; Konishi I; Nanbu K; Tsuruta Y; Kusakari T; Kariya M; Kita M; Fujii S
    Cancer; 2002 Feb; 94(4):997-1005. PubMed ID: 11920468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferating cell nuclear antigen and Ki67 immunoreactivity in ameloblastomas.
    Meer S; Galpin JS; Altini M; Coleman H; Ali H
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Feb; 95(2):213-21. PubMed ID: 12582363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of proliferative activity by AgNOR and PCNA in prostatic tissues of ram lambs implanted with zeranol.
    Gulbahar MY; Yuksel H; Guvenc T; Okut H
    Reprod Domest Anim; 2005 Oct; 40(5):468-74. PubMed ID: 16149954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical validity of proliferating cell nuclear antigen as an objective marker for evaluating biologic features in patients with untreated prostate cancer.
    Miyamoto S; Ito K; Kurokawa K; Suzuki K; Suzuki K; Yamanaka H
    Int J Urol; 2006 Jun; 13(6):767-72. PubMed ID: 16834658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ovate pontic design: a histologic observation in humans.
    Zitzmann NU; Marinello CP; Berglundh T
    J Prosthet Dent; 2002 Oct; 88(4):375-80. PubMed ID: 12447213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis, PCNA and p53 in hepatocellular carcinoma.
    Paiva C; Oshima CT; Lanzoni VP; Forones NM
    Hepatogastroenterology; 2002; 49(46):1058-61. PubMed ID: 12143201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferating cell nuclear antigen (PCNA) activity in hepatocellular carcinoma, benign peri-neoplastic and normal liver.
    Mun KS; Cheah PL; Baharudin NB; Looi LM
    Malays J Pathol; 2006 Dec; 28(2):73-7. PubMed ID: 18376794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of the results of Mise's surgical technic for alveolar mucosal hyperplasia].
    Krmpotić I
    Acta Stomatol Croat; 1983; 17(1):73-9. PubMed ID: 6579832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.